2020-11-02T10:20:43-06:00 2019-12-31 ERNST & YOUNG US LLP 5 TIMES SQUARE NEW YORK NY 15222 990 2019-01-01 237348742 The Transplantation Society % DENISE RAINVILLE TRAN 5148741717 505 Rene-Levesque BLVD WEST SUITE Montreal Quebec CA H2Z 1Y7 JEAN-PIERRE MONGEAU EXECUTIVE DIRECTOR 5148741717 2020-10-30 true YUCEN ZHONG P01593150 2127736170 164.57.159.254 26308520203075000018 2020-11-02 P 8C0075DE128CBD006CA99682002307B42C2396E3 6A69C49544F75893C57D7E77D9A98363E439FCB3 2019 2021-01-29 14:40:06Z Jean-Pierre Mongeau 505 Rene-Levesque BLVD WEST Montreal Quebec CA 3162715 false X www.tts.org X 1972 DE INTERNATIONAL LEADERSHIP IN THE SCIENCE, EDUCATION, ETHICS AND PRACTICE OF TRANSPLANTATION. 19 19 0 20 0 0 514274 423505 4355543 1430336 477161 339986 0 0 5346978 2193827 244412 133000 0 0 656593 654971 0 0 0 3516241 1398121 4417246 2186092 929732 7735 10871663 11642358 877560 662939 9994103 10979419 X THE TRANSPLANTATION SOCIETY PROVIDES THE FOCUS FOR GLOBAL LEADERSHIP IN TRANSPLANTATION FOR THE DEVELOPMENT OF THE SCIENCE AND CLINICAL, PRACTICE, SCIENTIFIC COMMUNICATION, CONTINUING EDUCATION AND GUIDANCE ON THE ETHICAL PRACTICE. false false 592453 0 966041 PROGRAM AND MAGAZINE PUBLICATIONS INCLUDING WEBSITE DEVELOPMENT AND WEBINARS AVAILABLE TO MEMBERS ONLY. THESE PUBLICATIONS RELATE SPECIFICALLY TO THE FIELD OF ORGAN TRANSPLANTATION. 133000 133000 0 AN INTERNATIONAL FORUM FOR THE WORLD-WIDE ADVANCEMENT OF ORGAN TRANSPLANTATION INCLUDING A FOCUS ON - DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE - SCIENTIFIC COMMUNICATION - CONTINUING EDUCATION - GUIDANCE ON THE ETHICAL PRACTICE OF TRANSPLANTATION. THE ORGANIZATION ACHIEVES THIS FOCUS BY MAKING GRANTS TO SECTION AND REGIONAL SOCIETIES FOR THE PURPOSE OF TRAVEL, RESEARCH FELLOWSHIP, AND RECOGNIZING INDIVIDUALS WHO HAVE MADE OUTSTANDING CONTRIBUTIONS IN TRANSPLANTATION. THE PRIMARY AWARDS AND GRANTS ARE: 1) THE MEDAWAR PRIZE, NAMED AFTER SOCIETY CO-FOUNDER SIR PETER MEDAWAR, IS RECOGNIZED AS THE WORLD'S HIGHEST DEDICATED AWARD FOR THE MOST OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION. THE MEDAWAR PRIZE HAS BEEN AWARDED TO TWO OR MORE RECIPIENTS AT EACH OF THE ORGANIZATION'S BIENNIAL CONGRESSES SINCE 1990. THE AWARD IS MADE POSSIBLE BY A GENEROUS GRANT FROM NOVARTIS PHARMA AG WHO AGREED THAT A PRESTIGIOUS PRIZE BE ESTABLISHED AND MAINTAINED TO RECOGNIZE THE OUTSTANDING INVESTIGATORS WHOSE CONTRIBUTIONS HAVE HAD SUCH A PROFOUND INFLUENCE ON THE FIELD OF ORGAN TRANSPLANTATION. THE MEDAWAR PRIZE IS UNIVERSALLY CONSIDERED TO BE COMMENSURATE WITH THE MOST OUTSTANDING WORLD PRIZES FOR SCIENTIFIC ACHIEVEMENT. 2) TTS RESEARCH FELLOWSHIPS ARE OFFERED FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT OF A FULL TTS MEMBER. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 3)TRAVEL GRANTS FOR YOUNG INVESTIGATORS AND FOR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF THE ORGANIZATION. 309325 0 138750 EVENTS HELD IN A VARIETY OF GLOBAL VENUES WHERE MEMBERS OF THE COMMUNITY ARE BROUGHT TOGETHER TO DISCUSS ADVANCEMENTS IN ORGAN TRANSPLANTATION. ORGAN TRANSPLANTATION IS A SUCCESSFUL THERAPY FOR END STAGE ORGAN FAILURE OF THE KIDNEY, LIVER, HEART, LUNG, PANCREAS AND INTESTINE. TRANSPLANTATION OF CELLS AND TISSUES ALSO TRANSFORMED THE THERAPEUTIC OPTIONS FOR PATIENTS WITH MALIGNANT HAEMATOLOGICAL DISEASE, EYE DISEASEAND ORTHOPAEDIC DISEASE, AND HAS THE POTENTIAL TO ALTER SIGNIFICANTLY THETHERAPEUTIC OPTIONS FOR PATIENTS WITH DIABETES AND A RANGE OF DISORDERS. THE ACCESS OF PATIENTS TO TRANSPLANTATION THERAPY VARIES WIDELY ACROSS THE GLOBE, PARTLY DETERMINED BY THE UNDERLYING LEVEL OF ECONOMIC DEVELOPMENT IN DIFFERENT STATES AND PARTLY DETERMINED BY OTHER FACTORS SUCH AS THE AVAILABILITY OF ORGAN, CELL AND TISSUE DONORS, OR THE SPECIALIZED PROVISION OF HEALTH SERVICES. THE ORGANIZATION HAS DETERMINED THAT IT WILL SEEK TO ADDRESS GLOBAL INEQUITIES IN TRANSPLANTATION THERAPY, IN ORDER TO FACILITATE APPROPRIATE ACCESS TO TRANSPLANTATION FOR ALL PATIENTS WHO WOULD BENEFIT. 229450 0 325545 1264228 true true false false false false false false false false true false false false true false true false false true true true true false false false false true true false false false false false false false false false false false false false false false false false false true 0 0 0 false true CA false false false false false false false false false false X 19 19 false false false false true true true true true false false true true true true false false true true false DE X DENISE RAINVILLE 5148741717 505 Rene-Levesque BLVD STE 1401 Montreal Quebec CA H2Z 1Y7 Jean-Pierre Mongeau Executive Director 40.0 0.0 X 93981 0 0 Dr Stefan Tullius SENIOR Treasurer 1.0 0.0 X X 0 0 0 Dr Mehmet Haberal President 2.0 0.0 X X 0 0 0 Dr Marcelo Cantarovic president-elect 1.0 0.0 X X 0 0 0 MEDHAT ASKAR COUNCILOR 1.0 0.0 X 0 0 0 STEVEN J CHADBAN COUNCILOR 0.5 0.0 X 0 0 0 Hiroto Egawa Councilor 1.0 0.0 X 0 0 0 Peter j Friend Councilor 1.0 0.0 X 0 0 0 Gabriel E Gondolesi Councilor 1.0 0.0 X 0 0 0 S Adibul Hasan Councilor 0.5 0.0 X 0 0 0 Minnie Sarwal Treasurer 1.0 0.0 X X 0 0 0 Peter g Stock Councilor 1.0 0.0 X 0 0 0 Dr John Fung Secretary 1.0 0.0 X X 0 0 0 Dr Nancy Ascher IMMEDIATE PAST President 1.0 0.0 X X 0 0 0 Dr Elmi Muller vice president 1.0 0.0 X X 0 0 0 Mustafa Al-Mousawi Councilor 1.0 0.0 X 0 0 0 Karen Dwyer Councilor 0.5 0.0 X 0 0 0 Maria Gerbase de Lima Councilor 0.5 0.0 X 0 0 0 Marti Manyalich Vidal Councilor 0.5 0.0 X 0 0 0 Megan Sykes Councilor 0.5 0.0 X 0 0 0 93981 0 0 0 false false false JJ Editorial LLC 201 Shannon Oaks Circle Suite 124 CARY NC 27511 journal management 227228 1 212855 210650 423505 JOURNALS 511110 966041 966041 MEETINGS AND REGISTRATION 911430 189724 189724 MANAGEMENT FEES 561000 274571 274571 1430336 259708 259708 0 0 0 0 0 1049166 968888 80278 80278 80278 0 0 0 0 0 0 0 0 0 0 2193827 1430336 339986 85000 85000 13500 13500 34500 34500 0 93981 93981 0 471490 104041 367449 0 41511 9367 32144 47989 9704 38285 129775 129775 1956 504 1452 21930 21930 0 0 47890 47890 10750 1495 9255 0 24546 5292 19254 71795 3063 68732 107908 45650 62258 0 74615 6841 67774 80953 16237 64716 0 204704 203121 1583 0 0 12011 3685 8326 14364 14364 JOURNALS 592453 592453 LOSS ON FOREIGN EXCHANGE 2205 2205 ALL OTHER EXPENSES 266 266 2186092 1264228 921864 0 1958058 1394995 152640 157511 0 0 240590 219534 0 0 0 0 0 0 0 0 38436 52962 340573 298632 23676 41941 8458263 9728302 0 0 0 0 0 0 0 47113 10871663 11642358 572357 417385 0 0 301942 222422 0 0 0 0 0 0 0 0 3261 15340 0 7792 877560 662939 X 9129198 9977047 864905 1002372 9994103 10979419 10871663 11642358 7735 977581 X false true X true false X 935906 397613 328896 514274 423505 2600194 1193713 4302197 1656188 4355543 1430336 12937977 0 0 0 2129619 4699810 1985084 4869817 1853841 15538171 1198649 1198649 0 1198649 1198649 14339522 189140 194626 177958 231979 259708 1053411 0 189140 194626 177958 231979 259708 1053411 0 0 2318759 4894436 2163042 5101796 2113549 16591582 0.86426 0.94255 0.06349 0.05745 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8802 7502 1300 197532 156891 40641 134238 134238 0 41941 0 DEFERRED LEASE INDUCEMENT 7792 7792 3171408 977581 977581 2193827 2193827 2122711 2122711 63381 63381 2186092 SCHEDULE D, PART XII, LINE 4b OTHER: congress expenses over revenue $63,381 true North America 1 16 Program Services maintenance of office 1130964 North America 0 0 Investments 9885813 North America 0 0 Grantmaking 4500 East Asia and the Pacific 0 0 Grantmaking 9000 Europe (Including Iceland and Greenland) 0 0 Grantmaking 9500 South America 0 0 Grantmaking 5500 South Asia 0 0 Grantmaking 5000 Sub-Saharan Africa 0 0 Grantmaking 1000 1 16 1 16 11051277 11051277 Travel grant East Asia and the Pacific 4 4000 WIRE Travel grant Europe (Including Iceland and Greenland) 6 6000 WIRE Travel grant North America 4 4500 WIRE Travel grant South America 3 5500 WIRE Travel grant South Asia 5 5000 WIRE Travel grant Sub-Saharan Africa 1 1000 WIRE false false false false false false Organization's Procedures for Monitoring Use of Grant Funds Outside the US THE ORGANIZATION'S PROCESS FOR MONITORING THE USE OF GRANT FUNDS WHETHER IN THE US OR INTERNATIONALLY STARTS WITH THE SELECTION CRITERIA FOR EACH SUCH AWARD OR GRANT: 1) RESEARCH FELLOWSHIPS ARE ONLY OFFERED TO A "FULL" MEMBER FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT. FULL MEMBERS SHALL BE PHYSICIANS, SURGEONS, SCIENTISTS OR OTHER SPECIALISTS, WHO ARE ACTIVELY ENGAGED IN THE SCIENCE OR CLINICAL PRACTICE OF ORGAN, CELL AND TISSUE TRANSPLANTATION. PHYSICIANS AND SURGEONS SHALL HAVE ADVANCED TRAINING OR EQUIVALENT EXPERIENCE IN THE SCIENCE AND PRACTICE OF ORGAN AND TISSUE TRANSPLANTATION. NON-PHYSICIANS, INCLUDING COORDINATORS, STATISTICIANS, AND POLICY MAKERS WHO HOLD A DOCTORAL DEGREE, A BACHELORS DEGREE, OR EQUIVALENT RELEVANT CERTIFICATION MUST HAVE PROFESSIONAL EXPERIENCE IN THE FIELD OF TRANSPLANTATION WITH CONTINUING AND ACTIVE INVOLVEMENT IN CLINICAL MEDICINE OR RESEARCH, OR TRANSPLANTATION PUBLIC POLICY AS DETERMINED BY THE MEMBERSHIP COMMITTEE. THE PROCESS OF LIMITING RESEARCH FELLOWSHIPS ONLY TO FULL MEMBERS ALLOWS THE ORGANIZATION TO ENSURE THE RECIPIENTS HAVE THE PROPER CREDENTIALS TO USE THE FUNDS TO FURTHER THE ORGANIZATION'S TAX EXEMPT PURPOSES. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 2) SINCE THE MEDAWAR PRIZE AND THE RECOGNITION AWARDS ARE ONLY PRESENTED TO RECIPIENTS WHO MAKE OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION, THE SELECTION CRITERIA ENSURE THAT THE INVESTIGATOR(S) RECEIVING THESE GRANTS ARE AMONG THE MOST INFLUENTIAL IN THE FIELD OF ORGAN TRANSPLANTATION AND AS A RESULT THIS AWARD SUPPORTS THE FURTHERANCE OF THE ORGANIZATION'S MISSION. 3) TRAVEL GRANTS ARE PRESENTED TO YOUNG INVESTIGATORS OR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF THE ORGANIZATION. PRIORITY IS GIVEN TO THOSE YOUNG INVESTIGATORS UNDER 40 YEARS OF AGE WITH THE FIRST AUTHORSHIP OF AN ACCEPTED ABSTRACT (ESPECIALLY THOSE FROM DEVELOPING COUNTRIES). AGAIN THE REQUIREMENT THAT THE RECIPIENTS BE MEMBERS OF THE ORGANIZATION AND THE SELECTION CRITERIA ENABLE THE ORGANIZATION TO MONITOR THAT THE FUNDS WILL BE USED IN ACCORDANCE WITH ITS EXEMPT PURPOSE. In addition, the award recipient must travel to the conference or meeting and be physically present in order to receive the funding. true International Society of Nephrology 340 north ave 3rd fl cranford NJ 07016 591776707 501(c)(3) 52000 fmv sponsorship of works Transplant Therapeutics consortium 1730 E River Road Tucson AZ 85718 201991334 501(c)(3) 25000 FMV sponsorship of workshop 2 Description of Organization's Procedures for Monitoring the Use of Grants THE ORGANIZATION'S PROCESS FOR MONITORING THE USE OF GRANT FUNDS WHETHER IN THE US OR INTERNATIONALLY STARTS WITH THE SELECTION CRITERIA FOR EACH SUCH AWARD OR GRANT: 1) RESEARCH FELLOWSHIPS ARE ONLY OFFERED TO A "FULL" MEMBER FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT. FULL MEMBERS SHALL BE PHYSICIANS, SURGEONS, SCIENTISTS OR OTHER SPECIALISTS, WHO ARE ACTIVELY ENGAGED IN THE SCIENCE OR CLINICAL PRACTICE OF ORGAN, CELL AND TISSUE TRANSPLANTATION. PHYSICIANS AND SURGEONS SHALL HAVE ADVANCED TRAINING OR EQUIVALENT EXPERIENCE IN THE SCIENCE AND PRACTICE OF ORGAN AND TISSUE TRANSPLANTATION. NON-PHYSICIANS, INCLUDING COORDINATORS, STATISTICIANS, AND POLICY MAKERS WHO HOLD A DOCTORAL DEGREE, A BACHELORS DEGREE, OR EQUIVALENT RELEVANT CERTIFICATION MUST HAVE PROFESSIONAL EXPERIENCE IN THE FIELD OF TRANSPLANTATION WITH CONTINUING AND ACTIVE INVOLVEMENT IN CLINICAL MEDICINE OR RESEARCH, OR TRANSPLANTATION PUBLIC POLICY AS DETERMINED BY THE MEMBERSHIP COMMITTEE. THE PROCESS OF LIMITING RESEARCH FELLOWSHIPS ONLY TO FULL MEMBERS ALLOWS THE ORGANIZATION TO ENSURE THE RECIPIENTS HAVE THE PROPER CREDENTIALS TO USE THE FUNDS TO FURTHER THE ORGANIZATION'S TAX EXEMPT PURPOSES. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 2) SINCE THE MEDAWAR PRIZE AND THE RECOGNITION AWARDS ARE ONLY PRESENTED TO RECIPIENTS WHO MAKE OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION, THE SELECTION CRITERIA ENSURE THAT THE INVESTIGATOR(S) RECEIVING THESE GRANTS ARE AMONG THE MOST INFLUENTIAL IN THE FIELD OF ORGAN TRANSPLANTATION AND AS A RESULT THIS AWARD SUPPORTS THE FURTHERANCE OF THE ORGANIZATION'S MISSION. 3) TRAVEL GRANTS ARE PRESENTED TO YOUNG INVESTIGATORS OR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF ORGANIZATION. PRIORITY IS GIVEN TO THOSE YOUNG INVESTIGATORS UNDER 40 YEARS OF AGE WITH THE FIRST AUTHORSHIP OF AN ACCEPTED ABSTRACT (ESPECIALLY THOSE FROM DEVELOPING COUNTRIES). AGAIN, THE REQUIREMENT THAT THE RECIPIENTS BE MEMBERS OF THE ORGANIZATION AND THE SELECTION CRITERIA ENABLE THE ORGANIZATION TO MONITOR THAT THE FUNDS WILL BE USED IN ACCORDANCE WITH ITS EXEMPT PURPOSE. ORGANIZATION'S MEMBERS PART VI, LINE 6 THE ORGANIZATION DOES NOT HAVE STOCKHOLDERS BUT DOES HAVE 5 CATEGORIES OF MEMBERS: 1) FULL MEMBERS WHICH MUST BE PHYSICIANS, SURGEONS, SCIENTISTS OR OTHER SPECIALISTS, WHO ARE ACTIVELY ENGAGED IN THE SCIENCE OR CLINICAL PRACTICE OF ORGAN, CELL OR TISSUE TRANSPLANTATION. 2) TRAINEE MEMBERS SHALL INCLUDE INDIVIDUALS ENROLLED IN PRE OR POSTDOCTORAL TRAINING PROGRAMS RELEVANT TO THE SCIENCE AND CLINICAL PRACTICE OF ORGAN, CELL OR TISSUE TRANSPLANTATION, AND INDIVIDUALS WHO HAVE COMPLETED THEIR TRAINING BUT HAVE NOT YET QUALIFIED FOR FULL MEMBERSHIP. TRAINEE MEMBERS MAY NOT VOTE OR HOLD OFFICE ON THE COUNCIL BUT MAY SERVE ON THE COMMITTEES. 3) EMERITUS MEMBERS SHALL BE FULL MEMBERS WHO HAVE ATTAINED THE AGE OF 65 OR HAVE RETIRED FROM PRACTICE IN THE FIELD OF TRANPLANTATION AND WHO FORMALLY REQUEST EDEMERITUS MEMBERSHIP. EMERITUS MEMBERS MAY NOT VOTE OR HOLD OFFICE ON THE COUNCIL BUT MAY SERVE ON THE COMMITTEES AND SHALL BE EXEMPT FROM PAYMENT OF ANNUAL MEMBERSHIP DUES. 4) ASSOCIATE MEMBERS SHALL INCLUDE INDIVIDUALS WHO HAVE DEMONSTRATED A SUSTAINED AND CONTINUED INTEREST IN THE FIELD OF TRANSPLANTATION BUT WHO DO NOT QUALIFY FOR FULL OR TRAINEE MEMBERSHIP. THESE INDIVIDUALS MAY NOT VOTE, HOLD OFFICE, OR SERVE ON COMMITTEES BUT WILL HAVE ALL OTHER SOCIETAL PRIVILEGES (I.E. PHARMACEUTICAL REPRESENTATIVES). 5) HONORARY MEMBERS SHALL BE INVITED TO BECOME HONORARY MEMBERS BY THE COUNCIL OF THE SOCIETY AND SHALL BE INDIVIDUALS WITH A DISTINGUISHED RECORD IN TRANSPLANTATION IRRESPECTIVE OF PROFESSIONAL DISCIPLINE. HONORARY MEMBERS SHALL NOT HAVE THE RIGHT TO VOTE OR HOLD OFFICE ON THE COUNCIL AND SHALL BE EXEMPT FROM PAYMENT OF ANNUAL MEMBERSHIP DUES. A PERSON MAY APPLY TO BECOME A MEMBER BY SUBMITTING A COMPLETED APPLICATION ALONG WITH THE NECESSARY DOCUMENTATION AND THE WRITTEN RECOMMENDATION OF TWO MEMBERS. THE COUNCIL BY A VOTE OF A MAJORITY OF ITS MEMBERS SHALL APPROVE AND ELECT THE MEMBERS. ELECTION OF GOVERNING BODY & DECISIONS OF GOVERNING BODY PART VI, QUESTION 7A THE ORGANIZATION DOES HAVE MEMBERS WHO MAY ELECT MEMBERS OF THE GOVERNING BODY. IN ACCORDANCE WITH THE TERMS AND REQUIREMENTS OF ITS GOVERNING DOCUMENTS (I.E. BYLAWS), THE PRESIDENT, PRESIDENT-ELECT, AND PAST PRESIDENT SHALL SERVE FOR 2 YEARS; THE VICEPRESIDENT, THE SECRETARY, AND THE TREASURERS SHALL NORMALLY SERVE FOR 4 YEARS. THE FULL MEMBERS (AS DESCRIBED IN SCHEDULE O DESCRIPTION FOR PART VI, QUESTION 6)RECEIVE ELECTION BALLOTS TO ELECT THESE BOARD OF DIRECTOR POSITIONS. PART VI, QUESTION 7B CERTAIN DECISIONS OF THE GOVERNING BODY ARE SUBJECT TO THE APPROVAL OF THE MEMBERS. IN ADDITION TO THE PRESIDENT, PRESIDENT-ELECT, PAST PRESIDENT, THE VICE PRESIDENT, THE SECRETARY, THE TREASURERS, TWELVE COUNCILORS-AT-LARGE REPRESENTING NORTH AMERICA, LATIN AMERICA, EUROPE,ASIA, AFRICA/MIDDLE EAST, AND OCEANIA SHALL SERVE AS THE COUNCIL OF THE SOCIETY, THUS CONSISTING OF NINETEEN PERSONS. ANY MAJOR DECISIONS OF THE ORGANIZATION MUST BE APPROVED BY MAJORITY VOTE BY THIS COUNCIL. THIS COUNCIL APPOINTS FULL MEMBERS TO SERVE ON STANDING OR SPECIAL COMMITTEES FROM TIME TO TIME TO DO SUCH THINGS AND HAVE SUCH POWERS AND SERVE UPON SUCH TERMS AS THE RESOLUTION ESTABLISHING THE COMMITTEE SHALL PROVIDE. ACTIONS OF ALL COMMITTEES SHALL BE SUBJECT TO REVIEW AND APPROVAL BY THE COUNCIL. REVIEW PROCESS FOR FORM 990 PART VI, LINE 11B BEFORE THE FORM 990 IS FILED IT IS REVIEWED BY THE ORGANIZATION'S EXECUTIVE DIRECTOR IN CONSULTATION WITH THE ORGANIZATION'S TAX ADVISORS, ERNST AND YOUNG, LLP. THE FINANCIAL REVIEW IS BASED ON THE ORGANIZATION'S AUDITED FINANCIAL STATEMENTS FOR THE RELEVANT TIME PERIOD. A COPY OF FORM 990 IS PROVIDED TO THE ORGANIZATION'S EXECUTIVE COMMITTEE PRIOR TO FILING WITH THE IRS. CONFLICT OF INTEREST POLICY PART VI, LINE 12C UPON EMPLOYMENT AND ANNUALLY THEREAFTER, EACH KEY EMPLOYEE AND OFFICER OF THE ORGANIZATION IS REQUIRED TO COMPLETE A CONFLICT OF INTEREST AND DISCLOSURE FORM, PROVIDING SUFFICIENT INFORMATION ABOUT HIS/HER PERSONAL INTERESTS AND RELATIONSHIPS SO THE THIRD PARTY PROVIDER CAN (1) DETERMINE WHETHER ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST MAY EXIST, AND (2) MONITOR WORK OR SERVICE ASSIGNMENTS TO AVOID PLACING THE KEY EMPLOYEE, OFFICER OR DIRECTOR IN A POSITION WHERE THERE MAY BE AN APPEARANCE, POTENTIAL OR ACTUAL, OF A CONFLICT OF INTEREST OR A QUESTION OF OBJECTIVITY. COMPENSATION APPROVAL PROCESS PART VI, LINES 15A & 15B ON AN ANNUAL BASIS, THE EXECUTIVE COMMITTEE EVALUATES AND APPROVES THE CURRENT SALARY OF THE ORGANIZATION'S EXECUTIVE DIRECTOR. THIS EVALUATION PROCESS INCLUDES A REVIEW OF COMPARABLE DATA FOR THE POSITION OF EXECUTIVE DIRECTOR FROM TAX EXEMPT ORGANIZATIONS IN THE MARKET WITH SIMILAR SIZE, DEMOGRAPHICS AND GEOGRAPHY. AVAILABILITY OF DOCUMENTS TO THE PUBLIC PART VI, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.